Alnylam Pharmaceuticals
ALNY
#567
Rank
NZ$71.96 B
Marketcap
NZ$542.61
Share price
-1.20%
Change (1 day)
28.01%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no dividend history for this company